The U.S. FDA may soon authorize a spring round of COVID-19 boosters for some people

The FDA may soon authorize a spring round of COVID-19 boosters for some people The Food and Drug Administration appears poised to make available the COVID-19 vaccines that target omicron as a second booster for people with weak immune systems and those ages 65 and older. NPR

...

The FDA ... may authorize a second booster with the bivalent vaccines for at least some people, such as those who are at high risk because they have compromised immune systems or are 65 and older, a federal official who was not authorized to speak publicly told NPR. A decision could be announced within weeks.

...